Cellectis (CLLS) Assets (2013 - 2026)
Cellectis (CLLS) posted Assets of $267.37 million for Q2 2026, down 24.5% from $353.97 million a year earlier and down 7.5% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Cellectis' Assets came in at $324.72 million, down 15.3% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of -7.1% (FY2020 to FY2025).
- In prior years, Cellectis' Assets was $383.54 million in FY2024 (+14.7%), $334.27 million in FY2023 (+28.0%), $261.22 million in FY2022 (-31.6%) and $382.08 million in FY2021 (-18.6%).
- The Q2 2026 figure stands as the lowest quarterly Assets since Q3 2023.
- On a year-over-year basis, Assets has declined in each of the last five quarters, with growth averaging 2.4% over the last eight quarters.
- The strongest year-over-year quarter for Assets in the past five years was Q3 2024, with growth of 88.8%; the weakest was Q3 2022, with a decline of 32.3%.
- According to Business Quant data, Assets for the three prior quarters was $289.19 million (Q1 2026), $324.72 million (Q4 2025) and $343.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Cellectis | 148.50 Mn | -604.89 Mn | - | 267.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 267.37 Mn |
| Mar 31, 2026 | 289.19 Mn |
| Dec 31, 2025 | 324.72 Mn |
| Sep 30, 2025 | 343.05 Mn |
| Jun 30, 2025 | 353.97 Mn |
| Mar 31, 2025 | 364.09 Mn |
| Dec 31, 2024 | 383.54 Mn |
| Sep 30, 2024 | 395.88 Mn |
| Jun 30, 2024 | 407.15 Mn |
| Mar 31, 2024 | 354.46 Mn |
| Dec 31, 2023 | 334.27 Mn |
| Sep 30, 2023 | 209.70 Mn |
| Jun 30, 2023 | 227.67 Mn |
| Mar 31, 2023 | 251.41 Mn |
| Dec 31, 2022 | 261.22 Mn |
| Sep 30, 2022 | 279.58 Mn |
| Jun 30, 2022 | 320.88 Mn |
| Mar 31, 2022 | 347.19 Mn |
| Dec 31, 2021 | 382.08 Mn |
| Sep 30, 2021 | 412.89 Mn |
API Access
Cellectis Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();